Acute aluminium phosphide poisoning is a large, though under-reported, problem throughout the world, particularly in the Indian subcontinent. Aluminium phosphide, which is readily available as a fumigant for stored cereal grains, sold under various brand names such as QuickPhos, Salphos and Celphos, is highly toxic, especially when consumed from a freshly opened container.
Signs, symptoms, and diagnosis
After ingestion, toxic features usually develop within a few minutes. The major lethal consequence of aluminium phosphide ingestion is profound circulatory collapse, and is reportedly secondary to these toxins generated, which lead due to direct effects on cardiomyocytes, fluid loss, and adrenal gland damage. The signs and symptoms are non-specific, dose dependent and evolve with time passing. The dominant clinical feature is severe hypotension refractory to dopamine therapy. Other features may include dizziness, fatigue, tightness in the chest, headache, nausea, vomiting, diarrhoea, ataxia, numbness, paraesthesia, tremor, muscle weakness, diplopia and jaundice. If severe inhalation occurs, the patient may develop acute respiratory distress syndrome, heart failure, arrhythmias, convulsion and coma. Late manifestation include liver and kidney toxicities. Death can result from profound shock, myocarditis and multi-organ failure. The diagnosis of AAlP usually depends on the clinical suspicion or history. In some nations, tablets of AlP are also referred to as "rice tablets" and, if there is a history of rice tablet ingestion, then it should be treated differently from other types of rice tablets that are made up of herbal products. For a silver nitrate test on gastric aspirate, diluted gastric content can be positive.
Mechanism of toxicity
The toxicity of aluminium phosphide is attributed to the liberation of phosphine gas, a cytotoxic compound that causes free radical mediated injury, inhibits vital cellular enzymes and is directly corrosive to tissues. The following reaction releases phosphine when AlP reacts with water in the body:
Management and outcome
The management of AAlPP remains purely supportive because no specific cure exists. Mortality rates approach 60%. Correction of metabolic acidosis is a cornerstone of treatment. The role of magnesium sulfate as a potential therapy in AlP poisoning may decrease the likelihood of a fatal outcome, and has been described in many studies.
Prognosis
Aluminium phosphide has a fatal dose of between. The mortality rates from AAlPP vary from 35 to 85 percent. The actual numbers of cases may be much larger, as less than five percent of those with AAlPP eventually reach a tertiary care center. Since 1992, when aluminium phosphide became freely available in the market, it had, reportedly, overtaken all other forms of deliberate poisoning, such as organophosphorus and barbiturate poisoning, in North India. In a 25-year-long study on 5,933 unnatural deaths in northwest India, aluminium phosphide poisoning was found to be the major cause of death among all cases of poisonings.
Incidents
It has been reported to be the most common method of suicidal death in North India. Deaths have also been reported in Iran. In January 2017, four children died at a trailer park in Amarillo, Texas, after the pesticide was used under the home to kill rats. Several incidents of death in travelers in Thailand and other parts of Southeast Asia may have been caused by aluminum phosphide or chlorpyrifos, an organophosphate insecticide, used in an attempt to kill bedbugs in hotels. In February 2020, aluminum phosphide poisoning resulted in one death and three serious injuries aboard a cargo ship traveling near France, as the result of a botched fumigation procedure. The CDC has classified phosphine as immediately dangerous to life at 50 parts per million. In a study from Saudi Arabia, poisoning was most common during fumigation of households.
